PDS Biotechnology Corp (PDSB)
3.49
-0.04
(-1.13%)
USD |
NASDAQ |
May 17, 16:00
3.49
0.00 (0.00%)
After-Hours: 20:00
PDS Biotechnology Research and Development Expense (Quarterly): 6.704M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 6.704M |
| December 31, 2023 | 7.466M |
| September 30, 2023 | 6.448M |
| June 30, 2023 | 8.005M |
| March 31, 2023 | 5.844M |
| December 31, 2022 | 16.16M |
| September 30, 2022 | 4.353M |
| June 30, 2022 | 3.762M |
| March 31, 2022 | 5.161M |
| December 31, 2021 | 3.389M |
| September 30, 2021 | 3.688M |
| June 30, 2021 | 2.764M |
| March 31, 2021 | 1.413M |
| December 31, 2020 | 2.478M |
| September 30, 2020 | 2.061M |
| June 30, 2020 | 1.414M |
| March 31, 2020 | 1.972M |
| December 31, 2019 | 1.348M |
| September 30, 2019 | 1.834M |
| June 30, 2019 | 1.887M |
| Date | Value |
|---|---|
| March 31, 2019 | 1.03M |
| December 31, 2018 | 15.50M |
| September 30, 2018 | 0.1941M |
| June 30, 2018 | 0.1686M |
| March 31, 2018 | 0.2011M |
| December 31, 2017 | 10.83M |
| September 30, 2017 | 6.913M |
| June 30, 2017 | 8.975M |
| March 31, 2017 | 7.590M |
| December 31, 2016 | 6.779M |
| September 30, 2016 | 6.724M |
| June 30, 2016 | 5.975M |
| March 31, 2016 | 5.347M |
| December 31, 2015 | 5.266M |
| September 30, 2015 | 6.508M |
| June 30, 2015 | 3.195M |
| March 31, 2015 | 2.871M |
| December 31, 2014 | 2.838M |
| September 30, 2014 | 2.419M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.348M
Minimum
Dec 2019
16.16M
Maximum
Dec 2022
4.407M
Average
3.539M
Median
Research and Development Expense (Quarterly) Benchmarks
| Syros Pharmaceuticals Inc | 24.66M |
| PAVmed Inc | 1.941M |
| Palatin Technologies Inc | 7.160M |
| iBio Inc | 1.535M |
| Chromocell Therapeutics Corp | 0.0491M |